BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gratwohl A, Baldomero H, Schwendener A, Rocha V, Apperley J, Frauendorfer K, Niederwieser D; Joint Accreditation Committee of the International Society for Cellular Therapy., European Group for Blood and Marrow Transplantation. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies. Bone Marrow Transplant 2009;43:275-91. [PMID: 19169283 DOI: 10.1038/bmt.2009.7] [Cited by in Crossref: 77] [Cited by in F6Publishing: 70] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Jeger A, Favre G, Lutz J, Stern M, Usel M, Rovo A, Rischewski J, Tichelli A, Gratwohl A, Halter J. Tumor incidence in related hematopoietic stem cell donors. Bone Marrow Transplant 2011;46:1240-4. [DOI: 10.1038/bmt.2010.291] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
2 Medd P, Monk I, Danby R, Malladi R, Clifford R, Ellis A, Roberts D, Hatton C, Vyas P, Littlewood T, Peniket A. Methotrexate dose delivery is more important than ciclosporin level in graft-versus-host disease prophylaxis following T-replete reduced-intensity sibling allogeneic stem cell transplant. Int J Hematol 2011;94:266-78. [DOI: 10.1007/s12185-011-0920-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant 2019;54:1575-85. [PMID: 30728439 DOI: 10.1038/s41409-019-0465-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 26.3] [Reference Citation Analysis]
4 Andersson ER, Lendahl U. Regenerative medicine: a 2009 overview. J Intern Med 2009;266:303-10. [PMID: 19765176 DOI: 10.1111/j.1365-2796.2009.02157.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
5 Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014;49:744-50. [PMID: 24637898 DOI: 10.1038/bmt.2014.55] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 13.8] [Reference Citation Analysis]
6 Nelson RP, Yu M, Schwartz JE, Robertson MJ, Hromas R, Fausel CA, Vance GH, Dlouhy SR, Baute JA, Cox EA, Wood LL, Srivastava S, Robertson KA, Haut PR, Farag SS, Abonour R, Cornetta K, Cripe LD. Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia. Bone Marrow Transplant 2010;45:1300-8. [DOI: 10.1038/bmt.2009.348] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
7 Gerull S, Arber C, Bucher C, Buser A, Gratwohl A, Halter J, Heim D, Tichelli A, Stern M. Cyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT. Bone Marrow Transplant 2011;46:740-6. [DOI: 10.1038/bmt.2010.187] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Walenda T, Bokermann G, Jost E, Galm O, Schellenberg A, Koch CM, Piroth DM, Drescher W, Brümmendorf TH, Wagner W. Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells. PLoS One 2011;6:e18012. [PMID: 21437259 DOI: 10.1371/journal.pone.0018012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
9 Peters C, Cornish JM, Parikh SH, Kurtzberg J. Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia. Pediatr Clin North Am 2010;57:27-46. [PMID: 20307710 DOI: 10.1016/j.pcl.2010.01.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
10 Schetelig J, Schaich M, Schäfer-Eckart K, Hänel M, Aulitzky WE, Einsele H, Schmitz N, Rösler W, Stelljes M, Baldus CD, Ho AD, Neubauer A, Serve H, Mayer J, Berdel WE, Mohr B, Oelschlägel U, Parmentier S, Röllig C, Kramer M, Platzbecker U, Illmer T, Thiede C, Bornhäuser M, Ehninger G; Study Alliance Leukemia. Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial. Leukemia 2015;29:1060-8. [PMID: 25434303 DOI: 10.1038/leu.2014.335] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
11 Passweg JR, Schanz U, Chalandon Y, Güngör T, Baldomero H, Heim D, Nair G, Medinger M, Masouridi-Levrat S, de Faveri GN, Tiercy JM; Swiss Blood Stem Cell Transplantation Group. High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities. Bone Marrow Transplant 2015;50:1201-5. [PMID: 26052916 DOI: 10.1038/bmt.2015.129] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
12 Sakellari I, Gavriilaki E, Mallouri D, Batsis I, Varelas C, Tagara S, Bousiou Z, Papathanasiou M, Vardi A, Papalexandri A, Vadikoliou C, Athanasiadou A, Lalayanni C, Fylaktou A, Antoniadis K, Anagnostopoulos A. Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies. Transplant Cell Ther 2021:S2666-6367(21)01101-5. [PMID: 34320443 DOI: 10.1016/j.jtct.2021.07.020] [Reference Citation Analysis]
13 Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kröger N, Kuball J, Lanza F, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2017;52:811-7. [PMID: 28287639 DOI: 10.1038/bmt.2017.34] [Cited by in Crossref: 210] [Cited by in F6Publishing: 195] [Article Influence: 42.0] [Reference Citation Analysis]
14 Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Kröger N, Farge-Bancel D, Gaspar HB, Marsh J, Mohty M, Peters C, Sureda A, Velardi A, Ruiz de Elvira C, Madrigal A; European Group for Blood and Marrow Transplantation. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013;48:1161-7. [PMID: 23584439 DOI: 10.1038/bmt.2013.51] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 9.3] [Reference Citation Analysis]
15 Morris C, Drake M, Apperley J, Iacobelli S, van Biezen A, Bjorkstrand B, Goldschmidt H, Harousseau JL, Morgan G, de Witte T, Niederwieser D, Gahrton G; Myeloma Subcommittee of Chronic Leukaemia Working Party of EBMT. Efficacy and outcome of autologous transplantation in rare myelomas. Haematologica 2010;95:2126-33. [PMID: 20971818 DOI: 10.3324/haematol.2010.022848] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
16 Trickett AE, Wall DM. Regulation of cellular therapy in Australia. Pathology 2011;43:627-34. [DOI: 10.1097/pat.0b013e32834b3cfa] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Duarte RF, Shaw BE, Marín P, Kottaridis P, Ortiz M, Morante C, Delgado J, Gayoso J, Goterriz R, Martínez-Chamorro C, Mateos-Mazón JJ, Ramírez C, de la Rubia J, Achtereekte H, Gandhi PJ, Douglas KW, Russell NH. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data. Bone Marrow Transplant 2011;46:52-8. [PMID: 20305700 DOI: 10.1038/bmt.2010.54] [Cited by in Crossref: 91] [Cited by in F6Publishing: 85] [Article Influence: 7.6] [Reference Citation Analysis]
18 Eduardo Fde P, Bezinelli LM, Hamerschlak N, Andrade CT, Morelli LR, Corrêa L. Oral care in Brazilian bone marrow transplant centers. Rev Bras Hematol Hemoter 2011;33:15-20. [PMID: 23284237 DOI: 10.5581/1516-8484.20110008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kang YG, Jeong JY, Lee TH, Lee HS, Shin JW. Synergistic Integration of Mesenchymal Stem Cells and Hydrostatic Pressure in the Expansion and Maintenance of Human Hematopoietic/Progenitor Cells. Stem Cells Int 2018;2018:4527929. [PMID: 29681947 DOI: 10.1155/2018/4527929] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Walenda T, Bokermann G, Ventura Ferreira MS, Piroth DM, Hieronymus T, Neuss S, Zenke M, Ho AD, Müller AM, Wagner W. Synergistic effects of growth factors and mesenchymal stromal cells for expansion of hematopoietic stem and progenitor cells. Exp Hematol 2011;39:617-28. [PMID: 21356269 DOI: 10.1016/j.exphem.2011.02.011] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 5.5] [Reference Citation Analysis]
21 Fedele R, Messina G, Martinello T, Gallo GA, Pontari A, Moscato T, Console G, Dattola A, Princi D, Cuzzola M, Alati C, Ronco F, Molica S, Irrera G, Martino M. Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimen. Clin Lymphoma Myeloma Leuk 2014;14:493-500. [PMID: 25034142 DOI: 10.1016/j.clml.2014.04.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
22 Holtick U, Albrecht M, Chemnitz JM, Theurich S, Shimabukuro-vornhagen A, Skoetz N, Scheid C, von Bergwelt-baildon M. Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults—a systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2015;94:179-88. [DOI: 10.1016/j.critrevonc.2014.12.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 46] [Article Influence: 7.1] [Reference Citation Analysis]
23 Chabannon C, Pamphilon D, Vermylen C, Gratwohl A, Niederwieser D, Mcgrath E, Lamers C, Lanza F, Slaper-cortenbach I, Madrigal A, Apperley J. Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program. Bone Marrow Transplant 2012;47:15-7. [DOI: 10.1038/bmt.2011.32] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
24 Auner HW, Mazzarella L, Cook L, Szydlo R, Saltarelli F, Pavlu J, Bua M, Giles C, Apperley JF, Rahemtulla A. High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma. Bone Marrow Transplant 2011;46:364-7. [PMID: 20562926 DOI: 10.1038/bmt.2010.141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
25 Oyekunle A, Klyuchnikov E, Ocheni S, Kröger N, Zander AR, Baccarani M, Bacher U. Challenges for allogeneic hematopoietic stem cell transplantation in chronic myeloid leukemia in the era of tyrosine kinase inhibitors. Acta Haematol 2011;126:30-9. [PMID: 21411987 DOI: 10.1159/000323662] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
26 Coluccia P, Montefusco V, Tunesi S, Avella M, Bompadre A, Longoni P, Milanesi M, De Carli A, Ravagnani F. Peripheral blood stem cell collection in multiple myeloma: a retrospective analysis of 6 years leukapheresis activity in 109 patients treated at the Istituto Nazionale dei Tumori of Milan. J Clin Apher 2009;24:134-40. [PMID: 19591198 DOI: 10.1002/jca.20203] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Vokurka S, Koza V, Lysak D, Karas M, Dvorak P, Jindra P, Hrabetova M, Vozobulova V. Successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patient. J Oncol 2010;2010:460859. [PMID: 20224640 DOI: 10.1155/2010/460859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Hicheri Y, Einsele H, Martino R, Cesaro S, Ljungman P, Cordonnier C. Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Transpl Infect Dis 2013;15:251-8. [PMID: 23465046 DOI: 10.1111/tid.12064] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
29 Mosevoll KA, Akkök ÇA, Hervig T, Melve GK, Bruserud Ø, Reikvam H. Stem cell mobilization and harvesting by leukapheresis alters systemic cytokine levels in patients with multiple myeloma. Cytotherapy 2013;15:850-60. [DOI: 10.1016/j.jcyt.2013.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
30 Lanza F, Campioni DC, Hellmann A, Milone G, Wahlin A, Walewski J, Spedini P, Fiamenghi C, Cuneo A, Knopińska W, Swierkowska-czeneszew M, Petriz J, Fruehauf S, Farge D, Mohty M, Passweg J, Ruuto T, Madrigal A, Johnsen HE. Individual Quality Assessment of Autografting by Probability Estimation for Clinical Endpoints: A Prospective Validation Study from the European Group for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation 2013;19:1670-6. [DOI: 10.1016/j.bbmt.2013.08.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
31 Su SH, Martel-Laferrière V, Labbé AC, Snydman DR, Kent D, Laverdière M, Béliveau C, Logvinenko T, Cohen S, Lachance S, Kiss T, Roy J. High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011;17:1012-7. [PMID: 20977944 DOI: 10.1016/j.bbmt.2010.10.025] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
32 Martin I, Baldomero H, Tyndall A, Niederwieser D, Gratwohl A. A Survey on Cellular and Engineered Tissue Therapies in Europe in 2008. Tissue Engineering Part A 2010;16:2419-27. [DOI: 10.1089/ten.tea.2010.0056] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
33 Al-ali HK, Bourgeois M, Krahl R, Edel E, Leiblein S, Poenisch W, Basara N, Lange T, Niederwieser D. The impact of the age of HLA-identical siblings on mobilization and collection of PBSCs for allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2011;46:1296-302. [DOI: 10.1038/bmt.2010.310] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
34 Hequet O. [The methods used to collect hematopoietic stem cells]. Transfus Clin Biol 2011;18:230-4. [PMID: 21397542 DOI: 10.1016/j.tracli.2011.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Mohamed SYA, Fadhil I, Hamladji R, Ali Hamidieh A, Fahmy O, Ladeb S, Alimoghaddam K, Elhaddad A, Ahmed Nacer R, Alsharif F, Rasheed W, Jahani M, Mousavi SA, Alseraihy A, Abdel-rahman F, Al Jefri A, Hussein AA, Alabdulaaly A, Ibrahim A, Bekadja M, Abboud M, Ahmed P, Dennison D, Bakr M, Benchekroun S, Hussain F, Othman TB, Aljurf M, Ghavamzadeh A. Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: Report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group. Hematology/Oncology and Stem Cell Therapy 2011;4:81-93. [DOI: 10.5144/1658-3876.2011.81] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
36 Ahmed SO, Ghavamzadeh A, Zaidi SZ, Baldomero H, Pasquini MC, Hussain F, Alimoghaddam K, Almohareb F, Ayas M, Hamidieh A, Mahmoud HK, Elhaddad A, Ben Othman T, Abdelkefi A, Sarhan M, Abdel-Rahman F, Adil S, Alkindi S, Bazarbachi A, Benchekroun S, Niederwieser D, Horowitz M, Gratwohl A, El Solh H, Aljurf M. Trends of hematopoietic stem cell transplantation in the Eastern Mediterranean region, 1984-2007. Biol Blood Marrow Transplant 2011;17:1352-61. [PMID: 21440654 DOI: 10.1016/j.bbmt.2011.01.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
37 Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A; European Group for Blood and Marrow Transplantation (EBMT). The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012;47:906-23. [PMID: 22543746 DOI: 10.1038/bmt.2012.66] [Cited by in Crossref: 141] [Cited by in F6Publishing: 133] [Article Influence: 14.1] [Reference Citation Analysis]
38 Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, Dufour C, Kröger N, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2018;53:1139-48. [PMID: 29540849 DOI: 10.1038/s41409-018-0153-1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 19.3] [Reference Citation Analysis]
39 Busca A. Cytomegalovirus (CMV) infection after hematopoietic stem cell transplantation: significant progress, but many unresolved problems. Expert Opin Biol Ther 2009;9:383-5. [PMID: 19344277 DOI: 10.1517/14712590902854448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
40 Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Apperley J, Frauendorfer K, Niederwieser D; for the Joint Accreditation Committee of the International Society for Cellular Therapy ISCT and the European Group for Blood and Marrow Transplantation EBMT (JACIE). The EBMT activity survey 2008: impact of team size, team density and new trends. Bone Marrow Transplant 2011;46:174-91. [DOI: 10.1038/bmt.2010.69] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
41 Gravel P, Naik A, Le Cotonnec J. Biosimilar rhG-CSFs: how similar are they? Targ Oncol 2012;7:3-16. [DOI: 10.1007/s11523-011-0187-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
42 Martin I, Baldomero H, Bocelli-Tyndall C, Slaper-Cortenbach I, Passweg J, Tyndall A. The survey on cellular and engineered tissue therapies in Europe in 2009. Tissue Eng Part A 2011;17:2221-30. [PMID: 21542713 DOI: 10.1089/ten.TEA.2011.0131] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
43 Shah A, Andersson TM, Rachet B, Björkholm M, Lambert PC. Survival and cure of acute myeloid leukaemia in England, 1971-2006: a population-based study. Br J Haematol 2013;162:509-16. [PMID: 23786647 DOI: 10.1111/bjh.12425] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 11.8] [Reference Citation Analysis]
44 Martín-antonio B, Suarez-lledo M, Arroyes M, Fernández-avilés F, Martínez C, Rovira M, Espigado I, Gallardo D, Bosch A, Buño I, Martínez-laperche C, Jiménez-velasco A, de la Cámara R, Brunet S, Nieto JB, Urbano-ispizua Á. A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT. Bone Marrow Transplant 2013;48:1205-11. [DOI: 10.1038/bmt.2013.43] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
45 Lupo-Stanghellini MT, Provasi E, Bondanza A, Ciceri F, Bordignon C, Bonini C. Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation. Hum Gene Ther. 2010;21:241-250. [PMID: 20121594 DOI: 10.1089/hum.2010.014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
46 Giebel S, Labopin M, Mohty M, Mufti GJ, Niederwieser D, Cornelissen JJ, Janssen JJ, Milpied N, Vindelov L, Petersen E, Arnold R, Bacigalupo A, Blaise D, Craddock C, Nagler A, Frassoni F, Sadus-Wojciechowska M, Rocha V. The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplant 2013;48:238-42. [PMID: 22773125 DOI: 10.1038/bmt.2012.131] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
47 Caunday O, Faucher C, Milpied N, Chabannon C. [Happy birthday to Joint Accreditation Committee for ISCT Europe and EBMT]. Med Sci (Paris) 2010;26:652-4. [PMID: 20619170 DOI: 10.1051/medsci/2010266-7652] [Reference Citation Analysis]
48 Bettens F, Passweg J, Schanz U, Chalandon Y, Heim D, Güngör T, Stussi G, Nicoloso G, Baldomero H, Gratwohl A, Tiercy JM. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms. Biol Blood Marrow Transplant 2012;18:608-16. [PMID: 21963878 DOI: 10.1016/j.bbmt.2011.09.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
49 Lapierre V, Rossi JF, Heshmati F, Azar N, Vekhof A, Makowski C, Moreau P, Caillot D, Auperin A, Chabannon C. Ancestim (r-metHuSCF) plus filgrastim and/or chemotherapy for mobilization of blood progenitors in 513 poorly mobilizing cancer patients: the French compassionate experience. Bone Marrow Transplant 2011;46:936-42. [PMID: 20956952 DOI: 10.1038/bmt.2010.231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
50 Suárez-González J, Martínez-Laperche C, Kwon M, Balsalobre P, Carbonell D, Chicano M, Rodríguez-Macías G, Serrano D, Gayoso J, Díez-Martín JL, Buño I. Donor Cell-Derived Hematologic Neoplasms after Hematopoietic Stem Cell Transplantation: A Systematic Review. Biol Blood Marrow Transplant 2018;24:1505-13. [PMID: 29410295 DOI: 10.1016/j.bbmt.2018.01.033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
51 Wils EJ, van der Holt B, Broers AE, Posthumus-van Sluijs SJ, Gratama JW, Braakman E, Cornelissen JJ. Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients. Haematologica 2011;96:1846-54. [PMID: 21859737 DOI: 10.3324/haematol.2011.047696] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
52 Basak GW, Jaksic O, Koristek Z, Mikala G, Basic-kinda S, Mayer J, Masszi T, Giebel S, Labar B, Wiktor-jedrzejczak W; on behalf of the Central and Eastern European Leukaemia Group (CELG). Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells: Plerixafor in patients with MM after autoSCT. European Journal of Haematology 2011;86:488-95. [DOI: 10.1111/j.1600-0609.2011.01605.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
53 Nivison-smith I, Dodds AJ, Dunckley H, Ma DDF, Moore JJ, Simpson JM, Szer J, Bradstock KF. Increased activity and improved outcome in unrelated donor haemopoietic cell transplants for acute myeloid leukaemia in Australia, 1992-2005: Unrelated donor HCT for AML. Internal Medicine Journal 2011;41:27-34. [DOI: 10.1111/j.1445-5994.2010.02262.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
54 Fløisand Y, Sioud M. Recent Advances in Hematopoietic Stem Cell Transplantation and Perspectives of RNAi Applications. In: Sioud M, editor. RNA Therapeutics. Totowa: Humana Press; 2010. pp. 505-21. [DOI: 10.1007/978-1-60761-657-3_30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
55 Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 2016;51:786-92. [PMID: 26901709 DOI: 10.1038/bmt.2016.20] [Cited by in Crossref: 228] [Cited by in F6Publishing: 217] [Article Influence: 38.0] [Reference Citation Analysis]
56 Bacigalupo A. Alternative donor transplants for severe aplastic anemia. Hematology Am Soc Hematol Educ Program 2018;2018:467-73. [PMID: 30504347 DOI: 10.1182/asheducation-2018.1.467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
57 Hübel K, Weingart O, Naumann F, Bohlius J, Fresen MM, Engert A, Wheatley K. Allogeneic stem cell transplant in adult patients with acute myelogenous leukemia: a systematic analysis of international guidelines and recommendations. Leukemia & Lymphoma 2011;52:444-57. [DOI: 10.3109/10428194.2010.546918] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
58 Holtick U, Albrecht M, Chemnitz JM, Theurich S, Skoetz N, Scheid C, von Bergwelt-Baildon M. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults. Cochrane Database Syst Rev 2014;:CD010189. [PMID: 24748537 DOI: 10.1002/14651858.CD010189.pub2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
59 Chatzidimitriou D, Gavriilaki E, Sakellari I, Diza E. Hematopoietic cell transplantation and emerging viral infections. J Med Virol 2010;82:528-38. [PMID: 20087928 DOI: 10.1002/jmv.21696] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
60 Yoshizato T, Watanabe-okochi N, Nannya Y, Ichikawa M, Takahashi T, Sato T, Masuda A, Yatomi Y, Tsuno NH, Kurokawa M, Takahashi K. Prediction model for CD34 positive cell yield in peripheral blood stem cell collection on the fourth day after G-CSF administration in healthy donors. Int J Hematol 2013;98:56-65. [DOI: 10.1007/s12185-013-1366-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 Estcourt LJ. Why has demand for platelet components increased? A review: Why has demand for platelet components increased? Transfusion Med 2014;24:260-8. [DOI: 10.1111/tme.12155] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
62 Kolb H, Simoes B, Schmid C. Stem cell transplants for patients with relapsed/refractory leukaemia: . Current Opinion in Hematology 2009;16:444-52. [DOI: 10.1097/moh.0b013e3283309647] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
63 Denning WL, Xu J, Guo S, Klug CA, Hel Z. Limited transplantation of antigen-expressing hematopoietic stem cells induces long-lasting cytotoxic T cell responses. PLoS One 2011;6:e16897. [PMID: 21379572 DOI: 10.1371/journal.pone.0016897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Kröger N, Bacher U, Bader P, Böttcher S, Borowitz MJ, Dreger P, Khouri I, Olavarria E, Radich J, Stock W, Vose JM, Weisdorf D, Willasch A, Giralt S, Bishop MR, Wayne AS. NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignancies. Biol Blood Marrow Transplant 2010;16:1325-46. [PMID: 20637879 DOI: 10.1016/j.bbmt.2010.07.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
65 Mastaglio S, Stanghellini MT, Bordignon C, Bondanza A, Ciceri F, Bonini C. Progress and prospects: graft-versus-host disease. Gene Ther 2010;17:1309-17. [PMID: 20508597 DOI: 10.1038/gt.2010.83] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
66 Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant 2015;50:476-82. [PMID: 25642761 DOI: 10.1038/bmt.2014.312] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 19.3] [Reference Citation Analysis]
67 Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A, Frauendorfer K; European Group for Blood and Marrow Transplantation EBMT. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011;46:485-501. [PMID: 21358689 DOI: 10.1038/bmt.2011.11] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 10.2] [Reference Citation Analysis]
68 Gratwohl A, Baldomero H. Trends of hematopoietic stem cell transplantation in the third millennium. Curr Opin Hematol 2009;16:420-6. [PMID: 19680124 DOI: 10.1097/MOH.0b013e328330990f] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
69 Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L. Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol. 2012;12:239-252. [PMID: 22437937 DOI: 10.1038/nri3174] [Cited by in Crossref: 497] [Cited by in F6Publishing: 468] [Article Influence: 49.7] [Reference Citation Analysis]
70 Akkök ÇA, Liseth K, Melve GK, Ersvær E, Hervig T, Bruserud Ø. Is there a scientific basis for a recommended standardization of collection and cryopreservation of peripheral blood stem cell grafts? Cytotherapy 2011;13:1013-24. [DOI: 10.3109/14653249.2011.574117] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
71 Akkök CA, Hervig T, Stamnesfet S, Nesthus I, Melve GK, Lassalle P, Bruserud O. Effects of peripheral blood stem cell apheresis on systemic cytokine levels in patients with multiple myeloma. Cytotherapy 2011;13:1259-68. [PMID: 21905955 DOI: 10.3109/14653249.2011.605117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]